Search results for the GEO ID: GSE12643
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM317322
GPL8300
type 2 diabetes subject 01 myotubes from type 2 diabetes subject Only sedentary male subjects were recruited. Patients with type 2 diabetes were either treated by diet alone or in combination with sulphonylurea or metformin, which were withdrawn one week prior to the study. The patients were all GAD65 antibody negative and without signs of diabetic retinopathy, nephropathy, neuropathy or macrovascular complications. type 2 diabetes subject 01
GSM317323
GPL8300
type 2 diabetes subject 02 myotubes from type 2 diabetes subject Only sedentary male subjects were recruited. Patients with type 2 diabetes were either treated by diet alone or in combination with sulphonylurea or metformin, which were withdrawn one week prior to the study. The patients were all GAD65 antibody negative and without signs of diabetic retinopathy, nephropathy, neuropathy or macrovascular complications. type 2 diabetes subject 02
GSM317324
GPL8300
type 2 diabetes subject 03 myotubes from type 2 diabetes subject Only sedentary male subjects were recruited. Patients with type 2 diabetes were either treated by diet alone or in combination with sulphonylurea or metformin, which were withdrawn one week prior to the study. The patients were all GAD65 antibody negative and without signs of diabetic retinopathy, nephropathy, neuropathy or macrovascular complications. type 2 diabetes subject 03
GSM317325
GPL8300
type 2 diabetes subject 04 myotubes from type 2 diabetes subject Only sedentary male subjects were recruited. Patients with type 2 diabetes were either treated by diet alone or in combination with sulphonylurea or metformin, which were withdrawn one week prior to the study. The patients were all GAD65 antibody negative and without signs of diabetic retinopathy, nephropathy, neuropathy or macrovascular complications. type 2 diabetes subject 04
GSM317326
GPL8300
type 2 diabetes subject 05 myotubes from type 2 diabetes subject Only sedentary male subjects were recruited. Patients with type 2 diabetes were either treated by diet alone or in combination with sulphonylurea or metformin, which were withdrawn one week prior to the study. The patients were all GAD65 antibody negative and without signs of diabetic retinopathy, nephropathy, neuropathy or macrovascular complications. type 2 diabetes subject 05
GSM317327
GPL8300
type 2 diabetes subject 06 myotubes from type 2 diabetes subject Only sedentary male subjects were recruited. Patients with type 2 diabetes were either treated by diet alone or in combination with sulphonylurea or metformin, which were withdrawn one week prior to the study. The patients were all GAD65 antibody negative and without signs of diabetic retinopathy, nephropathy, neuropathy or macrovascular complications. type 2 diabetes subject 06
GSM317328
GPL8300
type 2 diabetes subject 07 myotubes from type 2 diabetes subject Only sedentary male subjects were recruited. Patients with type 2 diabetes were either treated by diet alone or in combination with sulphonylurea or metformin, which were withdrawn one week prior to the study. The patients were all GAD65 antibody negative and without signs of diabetic retinopathy, nephropathy, neuropathy or macrovascular complications. type 2 diabetes subject 07
GSM317329
GPL8300
type 2 diabetes subject 08 myotubes from type 2 diabetes subject Only sedentary male subjects were recruited. Patients with type 2 diabetes were either treated by diet alone or in combination with sulphonylurea or metformin, which were withdrawn one week prior to the study. The patients were all GAD65 antibody negative and without signs of diabetic retinopathy, nephropathy, neuropathy or macrovascular complications. type 2 diabetes subject 08
GSM317330
GPL8300
type 2 diabetes subject 09 myotubes from type 2 diabetes subject Only sedentary male subjects were recruited. Patients with type 2 diabetes were either treated by diet alone or in combination with sulphonylurea or metformin, which were withdrawn one week prior to the study. The patients were all GAD65 antibody negative and without signs of diabetic retinopathy, nephropathy, neuropathy or macrovascular complications. type 2 diabetes subject 09
GSM317331
GPL8300
type 2 diabetes subject 10 myotubes from type 2 diabetes subject Only sedentary male subjects were recruited. Patients with type 2 diabetes were either treated by diet alone or in combination with sulphonylurea or metformin, which were withdrawn one week prior to the study. The patients were all GAD65 antibody negative and without signs of diabetic retinopathy, nephropathy, neuropathy or macrovascular complications. type 2 diabetes subject 10
GSM317332
GPL8300
Cont subject 01 myotubes from control subject The control subjects had normal glucose tolerance and no family history of diabetes. control subject 01
GSM317333
GPL8300
Cont subject 02 myotubes from control subject The control subjects had normal glucose tolerance and no family history of diabetes. control subject 02
GSM317334
GPL8300
Cont subject 03 myotubes from control subject The control subjects had normal glucose tolerance and no family history of diabetes. control subject 03
GSM317335
GPL8300
Cont subject 04 myotubes from control subject The control subjects had normal glucose tolerance and no family history of diabetes. control subject 04
GSM317336
GPL8300
Cont subject 05 myotubes from control subject The control subjects had normal glucose tolerance and no family history of diabetes. control subject 05
GSM317337
GPL8300
Cont subject 06 myotubes from control subject The control subjects had normal glucose tolerance and no family history of diabetes. control subject 06
GSM317338
GPL8300
Cont subject 07 myotubes from control subject The control subjects had normal glucose tolerance and no family history of diabetes. control subject 07
GSM317339
GPL8300
Cont subject 08 myotubes from control subject The control subjects had normal glucose tolerance and no family history of diabetes. control subject 08
GSM317340
GPL8300
Cont subject 09 myotubes from control subject The control subjects had normal glucose tolerance and no family history of diabetes. control subject 09
GSM317341
GPL8300
Cont subject 10 myotubes from control subject The control subjects had normal glucose tolerance and no family history of diabetes. control subject 10
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes